Pages that link to "Q39038214"
Jump to navigation
Jump to search
The following pages link to Sunitinib in kidney cancer: 10 years of experience and development. (Q39038214):
Displaying 3 items.
- DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma (Q90169815) (← links)
- Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment (Q90608594) (← links)
- Identification of low-dose multidrug combinations for sunitinib-naive and pre-treated renal cell carcinoma (Q95322793) (← links)